We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
If you’ve spent any time in a trial steering committee meeting this year, you already know the mood has shifted.
Germany remains one of the most attractive and most procedurally demanding countries in Europe to run a clinical trial. It
There’s a belief that quietly circulates in clinical operations teams, usually right after something has gone wrong: “The CRO is
Brazil has quietly become one of the more strategically important countries in global clinical research. It offers the advantages of
Ask any quality director who’s launched a product in the EU for the first time about what surprised them most,
Ask any clinical operations lead running a multi-country European trial what keeps them up at night, and “GCP audit readiness”
Historically, “monitoring” in the industry involved CRAs traveling to sites to meticulously verify data against source documents. While thorough, this
Focus on GMP, GCP, Regulatory Affairs, CSV, QMS, and Clinical Operations. CPHI Milan 2026 will take place from October 6
Oral solid dosage forms, including tablets and capsules, dominate the global pharmaceutical market due to OSD convenience and cost-effectiveness. However,
CPHI Milan 2026 will be held from 6–8 October 2026 at Fiera Milano, Italy, serving as a key venue for
The Indian pharmaceutical industry is at a crucial juncture, known as the “pharmacy of the world” for affordable generics. In
The global pharmaceutical industry will convene in Milan for CPHI Milan 2026 from 6–8 October 2026 at Fiera Milano, Italy,
Bioequivalence (BE) studies are essential for generic drug development, demonstrating that generics deliver the same active ingredients as brand-name drugs.
The generic pharmaceutical industry is at a critical juncture. Traditionally, the route to market for generics involved proving bioequivalence via
The global generic pharmaceutical industry plays a crucial role in healthcare, comprising over 90% of prescriptions in the U.S. and
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Write to us : bd@zenovel.com
Copyright © 2026 Zenovel. All rights reserved.
